2,982
Views
0
CrossRef citations to date
0
Altmetric
Review

Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 471-487 | Received 23 Oct 2022, Accepted 23 Feb 2023, Published online: 12 Mar 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.